Skip to main content
Fig. 3 | Journal of Cardiovascular Magnetic Resonance

Fig. 3

From: Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study

Fig. 3

Longitudinal measurements of RVEF over 18 months. There were significant changes in RVEF over time (p < 0.001). By Sidak-adjusted pairwise comparisons with the baseline, the mean RVEF showed a small but significant decrease at 6 and 12 months (p < 0.001 for both), that was no longer significant at 18 months (p = 0.08). Data shown as mean and 95% confidence intervals (vertical bars)

Back to article page